Pharmaceutical Contract Manufacturing Market worth US$311.95 billion by 2030 with 8.2% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 29, 2025 /PRNewswire/ -- The global Pharmaceutical Contract Manufacturing Market, valued at US$193.99 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for outsourcing services for GLP-1 manufacturing, the growing ADC outsourcing for commercialized products, and the development and patent expiry of blockbuster biologics, which are paving the way for key biosimilars. However, the pricing pressure in the US and Europe on innovator drugs, generics, and biosimilars, & investments for compliance with regulations such as Annex-1, PFAS restrictions are expected to restrict market growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201524381

Read More: PRNewswireNews - Jornalwebdigital